NicOx appointed Jason Menzo as director of marketing and Mark Puwal as national director of sales...Polynoma added Sara Zaknoen, M.D., as CMO, Andrew Buckland as CFO, and Patrick Mallon as COO...med fusion hired Kristen Champion, Ph.D., as technical director of molecular pathology, Neelam Dhiman, Ph.D., as technical director of microbiology, and Vivek Kumar, Ph.D., as technical director of chemistry and toxicology.
Mark McDonough is now CCO at CombiMatrix...Ceres named Steven E. Koonin, Ph.D., to its board of directors...Actinium Pharmaceuticals hired Enza Guagenti as CFO and Jack V. Talley as president and CEO...biOasis Technologies appointed Terry Pearson, Ph.D., Chris Fibiger, Ph.D., Michael Hutchison, Ron Erickson, and Greg Gubitz to its board of directors and elected Robin Hutchison as president and CEO and David Clark as CFO and corporate secretary.
CMC Biologics hired Patricio E. Massera as general manager...Harold H. Shlevin, Ph.D., is now COO at Galectin Therapeutics...Hovione hired Mike Ironside, Ph.D., as general manager, TTC and Conrad Winters, Ph.D., as drug product development director.
Syngenea added Martin Biggs, Ph.D., as sales manager for U.K. and Ireland and Rob van den Broek as European sales manager...Oxford Gene Technology appointed Peter Rigby as chairman of its scientific advisory board...Pulmatrix named Robert Clarke, Ph.D., as CEO...Stuart A. Arbuckle is the new CCO at Vertex...Codexis added David O’Toole as CFO.
Islet Sciences appointed Richard A. Franco, Sr. to its board of directors and Kevan Herold, M.D., and Morton Printz, Ph.D., to its scientific advisory board...Aushon BioSystems hired Martin Verhoef as CEO...Patrick Vink, M.D., joined Cubist Pharmaceuticals as svp and general manager of international business.
Shire named Steven Gillis, Ph.D., to its board of directors...Scott Walton is now CEO at Ameritox...Immunovative appointed Diego Martin, M.D., Ph.D., Frank Ondrey, M.D., Ph.D., Antoni Ribas, M.D., Ph.D., and Theresa Whiteside, Ph.D., to its scientific advisory board.